awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35810452-7FDFCAB0-A7A9-47F3-9AC4-6F8BC42437B1
Q35810452-7FDFCAB0-A7A9-47F3-9AC4-6F8BC42437B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35810452-7FDFCAB0-A7A9-47F3-9AC4-6F8BC42437B1
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary disease.
P2860
Q35810452-7FDFCAB0-A7A9-47F3-9AC4-6F8BC42437B1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35810452-7FDFCAB0-A7A9-47F3-9AC4-6F8BC42437B1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d41dbcdd41e0023e74dc4355d76c6df2b5fdacd1
P2860
Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.